Stockscreener 앱 받기
121.76
1.43%
-1.77
Abbott Laboratories 주식(ABT)의 최신 뉴스
Abbott Laboratories: Who is the newcomer to Pōkeno? - BusinessDesk | NZ
Abbott Laboratories (ABT) positioned to benefit as healthcare sector enters recovery phase - MSN
Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock for Income Investors - Chartmill
Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now? - Yahoo Finance
Abbott (ABT) Declines More Than Market: Some Information for Investors - Yahoo Finance Singapore
Options Corner: Abbott Laboratories Offer Economic Insulation Ahead Of Earnings - Benzinga
FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information - Cardiovascular Business
TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories - ACCESS Newswire
1 Healthcare Stock to Consider Right Now and 2 We Find Risky - FinancialContent
Assessing Abbott Laboratories (ABT) Valuation After The CES 2026 Launch Of Libre Assist AI Tool - simplywall.st
Dividend King Abbott Shows Why 52 Consecutive Increases Weren’t Luck With Strong Cash Flow Coverage - AOL.com
Dividend King Abbott Shows Why 52 Consecutive Increases Weren't Luck With Strong Cash Flow Coverage - 24/7 Wall St.
Abbott reportedly looks to expand CGM manufacturing plant in Ireland - MassDevice
C-Reactive Protein Testing Market Is Going to Boom |• Abbott • Siemens Healthineers - openPR.com
Nordea Investment Management AB Buys 18,974 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Unloaded Rep. Julia Letlow - MarketBeat
Abbott Laboratories (ABT) Expected to Announce Earnings on Thursday - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Target of Unusually Large Options Trading (NYSE:ABT) - MarketBeat
Retirement Planning Group LLC Grows Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Holdings Cut by Exencial Wealth Advisors LLC - MarketBeat
The Bull Case For Abbott Laboratories (ABT) Could Change Following Libre Assist AI Launch In Diabetes Care - simplywall.st
Gov't Didn't Allege Formula Was Contaminated, Abbott Says - Law360
ABT.SW Abbott Laboratories (SIX) volume spike 13 Jan 2026: CHF100 key - Meyka
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $154 - 富途牛牛
Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins - Yahoo Finance
Abbott, AtaCor Collaborate on Extravascular Implantable Cardioverter Defibrillator - Diagnostic and Interventional Cardiology
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Declares Quarterly Dividend of $0.63 - MarketBeat
MGO One Seven LLC Acquires 18,412 Shares of Abbott Laboratories $ABT - MarketBeat
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company - Yahoo Finance
GRIMES & Co WEALTH MANAGEMENT LLC Purchases 10,635 Shares of Abbott Laboratories $ABT - MarketBeat
CPC Advisors LLC Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief - Chicago Tribune
Abbott Laboratories Stock: Quiet Grind Higher as Wall Street Warms to the Recovery Story - AD HOC NEWS
Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Institutional Investors Show Confidence in Abbott’s Healthcare Strategy - AD HOC NEWS
Is the Market Bullish or Bearish on Abbott Laboratories? - Benzinga
Abbott (ABT) Gains Ground in Glucose Monitoring Market - GuruFocus
Abbott, AtaCor collab on extravascular ICDs - MassDevice
Abbott Laboratories (ABT) Investor Outlook: Exploring a 14.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Abbott Laboratories $ABT Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery - GlobeNewswire Inc.
Tema Etfs LLC Raises Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - MarketBeat
Abbott Laboratories stock (ABT) in focus: Exact Sciences vote date lands as earnings week nears - TechStock²
Abbott Laboratories $ABT Shares Sold by New York State Teachers Retirement System - MarketBeat
Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage - TechStock²
Parnassus Investments LLC Acquires New Shares in Abbott Laboratories $ABT - MarketBeat
Sumitomo Mitsui DS Asset Management Company Ltd Buys 8,678 Shares of Abbott Laboratories $ABT - MarketBeat
Bernstein Raises Price Target for Abbott Laboratories (ABT) to $154 | ABT Stock News - GuruFocus
Sanford C. Bernstein Issues Positive Forecast for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $152 From $157, Maintains Buy Rating - marketscreener.com
Oregon Public Employees Retirement Fund Purchases 48,548 Shares of Abbott Laboratories $ABT - MarketBeat
State of Alaska Department of Revenue Trims Stake in Abbott Laboratories $ABT - MarketBeat
Ferguson Wellman Capital Management Inc. Trims Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories to Acquire i-STAT Corp., a Leading Manufacturer of Point-of-Care Diagnostics - ADVFN
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $147 - 富途牛牛
Rep. Byron Donalds Sells Abbott Laboratories (NYSE:ABT) Stock - MarketBeat
Assessing Abbott Laboratories (ABT) Valuation After Libre Assist Expands Its Digital Diabetes Offering - Yahoo Finance
A Look At Abbott Laboratories (ABT) Valuation After Libre Assist AI Diabetes Feature Launch - simplywall.st
Is Abbott Laboratories stock protected from inflationJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - ulpravda.ru
February 27th Options Now Available For Abbott Laboratories (ABT) - Nasdaq
Abbott Laboratories $ABT Shares Purchased by HB Wealth Management LLC - MarketBeat
Robeco Institutional Asset Management B.V. Reduces Holdings in Abbott Laboratories $ABT - MarketBeat
Benjamin Edwards Inc. Purchases 12,683 Shares of Abbott Laboratories $ABT - MarketBeat
Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics (NASDAQ:EXAS) - Seeking Alpha
0.36%
2.18%
자본화:
|
볼륨(24시간):